ArticleAnnals of surgical oncology2026
Long-Term Results of Multiple Pulmonary Metastasectomies.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary metastases affect up to 30% of cancer patients, but the incidence depends on the primary tumor type. Advances in therapy have expanded indications for pulmonary metastasectomy beyond highly selected cases. This study investigated long-term outcomes and prognostic factors of repeated pulmonary metastasectomies in modern clinical practice.
methodsThis study analyzed the long-term results of 1503 pulmonary metastasectomies performed on 1106 consecutive patients at the Istituto Nazionale Tumori of Milan between 2003 and 2018, with a focus on multiple and repeated procedures, type of surgical resection, and key prognostic factors. Patients were stratified into three cohorts: single metastasis (SM, n = 530), multiple metastases (MM, n = 595), and recurrent metastases (RM, n = 378).
resultsThe 10 year survival rates were 35.5% overall, 41.1% for SM, 30.8% for MM, and 31.1% for RM. The median survivals were as 5.1, 5.4, 3.8, and 5.9 years respectively. Precision resection was the most common type of procedure (53.2%), with 54.0% survival at 5 years and 33.4% survival at 10 years. The 30 day postoperative mortality was 0.1% overall, 0% for SM, 0.3% for MM, and 0% for RM.
conclusionsThese findings highlight the feasibility and curative potential of multiple and repeated pulmonary metastasectomies for carefully selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.